Listings
In this section
Events
Excellence Awards
Buyer's Guides
12/18/2025 10:46:51
Home | Biopharma’s 2025 M&A boom
Editor's letter
Contents
Mimotopes Company Insight
Mimotopes
Briefing
News in Numbers
Latest News
Latest Deals
Datwyler
Optimal Clinical Trials Company Insight
In Depth
Biopharma’s 2025 M&A boom: Dealmaking surges as patent pressures intensify
High-value oncology deals drive China’s drug licensing boom
AI takes charge of data, but challenges linger
In a Honduran city, biotechs create gene therapy cocktails to fight aging
APAC’s rising stars beyond China
ASH 2025: AbbVie and Genmab’s Epkinly sets new standard in second-line FL
Syngene Company Insight
Listings
Events
Excellence Awards
Buyer's Guides
Next issue
12/18/2025 00:00:00